Bromide

Bromide

SCHEMBL7023734

Br.CCCN1CCCC(c2cccc(S(C)(=O)=O)c2)C1

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SIGMAR1 known ✓ Q99720 4/20 0.73
DRD3 P35462 11/20 0.98
DRD2 P14416 10/20 0.98
DRD4 P21917 7/20 0.65
DRD1 P21728 5/20 0.65
DRD5 P21918 5/20 0.65
NFKB1 P19838 1/20 0.64
PRCP P42785 1/20 0.64
EBP Q15125 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL5699015 1.00 DRD3 (0.98) DRD3DRD2SIGMAR1DRD4DRD1
SCHEMBL873078 0.99 DRD3 (1.00) DRD3DRD2SIGMAR1DRD4DRD1
SCHEMBL873812 0.99 DRD3 (1.00) DRD3DRD2SIGMAR1DRD4DRD1
SCHEMBL873549 0.99 DRD3 (1.00) DRD3DRD2SIGMAR1DRD4DRD1
SCHEMBL29369425 0.99 DRD3 (1.00) DRD3DRD2SIGMAR1DRD4DRD1
Hydrochloric Acid SCHEMBL5678691 0.98 DRD3 (0.98) DRD3DRD2SIGMAR1DRD4DRD1
Hydrochloric Acid SCHEMBL5678697 0.98 DRD3 (0.98) DRD3DRD2SIGMAR1DRD4DRD1
Hydrochloric Acid SCHEMBL29634866 0.98 DRD3 (0.98) DRD3DRD2SIGMAR1DRD4DRD1
SCHEMBL6880380 0.91 DRD3 (0.84) DRD3DRD2SIGMAR1DRD4DRD1
SCHEMBL6881711 0.91 DRD3 (0.84) DRD3DRD2SIGMAR1DRD4DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1274430-A2 COMPOUNDS FOR TREATING FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME PHARMACIA & UPJOHN COMPANY (US) 2003-01-15 EP claimed
WO-2001081343-A2 COMPOUNDS FOR TREATING FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME PHARMACIA & UPJOHN COMPANY (US) 2001-11-01 WO claimed